GENOMIC HEALTH INC's ticker is GHDX and the CUSIP is 37244C101. A total of 120 filers reported holding GENOMIC HEALTH INC in Q2 2015. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $213,000 | -12.0% | 4,233 | -40.1% | 0.00% | -50.0% |
| Q4 2017 | $242,000 | +272.3% | 7,063 | +181.3% | 0.00% | – |
| Q2 2016 | $65,000 | +18.2% | 2,511 | +14.0% | 0.00% | – |
| Q1 2016 | $55,000 | -6.8% | 2,203 | +32.1% | 0.00% | – |
| Q4 2015 | $59,000 | -89.6% | 1,668 | -93.8% | 0.00% | -100.0% |
| Q3 2015 | $566,000 | +3229.4% | 26,753 | +4222.0% | 0.00% | – |
| Q2 2015 | $17,000 | +13.3% | 619 | +28.7% | 0.00% | – |
| Q1 2015 | $15,000 | 0.0% | 481 | +3.7% | 0.00% | – |
| Q4 2014 | $15,000 | 0.0% | 464 | -14.5% | 0.00% | – |
| Q3 2014 | $15,000 | -6.2% | 543 | -6.5% | 0.00% | – |
| Q2 2014 | $16,000 | +6.7% | 581 | 0.0% | 0.00% | – |
| Q1 2014 | $15,000 | -11.8% | 581 | +1.8% | 0.00% | – |
| Q4 2013 | $17,000 | -71.7% | 571 | -70.7% | 0.00% | -100.0% |
| Q3 2013 | $60,000 | +81.8% | 1,948 | +86.1% | 0.00% | – |
| Q2 2013 | $33,000 | – | 1,047 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 13,668,866 | $353,955,000 | 3.71% |
| Camber Capital Management LP | 2,458,100 | $63,652,000 | 3.08% |
| Ghost Tree Capital, LLC | 200,000 | $5,179,000 | 1.50% |
| Tributary Capital Management, LLC | 206,291 | $5,342,000 | 0.78% |
| Motley Fool Asset Management LLC | 131,935 | $3,416,000 | 0.74% |
| CORRADO ADVISORS, LLC | 40,695 | $1,054,000 | 0.68% |
| Broadfin Capital, LLC | 270,400 | $7,002,000 | 0.68% |
| ACUTA CAPITAL PARTNERS, LLC | 48,800 | $1,264,000 | 0.61% |
| Motley Fool Wealth Management, LLC | 123,018 | $3,186,000 | 0.35% |
| TFS CAPITAL LLC | 61,773 | $1,600,000 | 0.29% |